Evaluation of safety of using incompatible plasma for therapeutic plasma exchange during shortage of AB plasma

John Jeongseok Yang, Kyong Suk Ryu, Jin Seok Kim, Yousun Chung, Hyungsuk Kim, Sang Hyun Hwang, Heung Bum Oh, Dae Hyun Ko

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Criteria for selection of FFP blood type has not been clearly established and use of group AB plasma is preferred by numerous transplantation protocols. Aims: This study assesses the safety and efficacy of alternative group A or B plasma in ABO incompatible solid organ transplantation. Materials & Methods: Alternative use of group A or B plasma (incompatible plasma) was inevitable during the shortage of group AB plasma. Experience from select number of patients during the period of extreme group AB plasma shortage is described. Results: The result of alternative use of group A or B plasma was within expectation, showing effective reduction of isoagglutinin titers for pre-operative desensitization and efficacy for treatment of post-operative patients. No immediate hemolytic transfusion reaction was reported. Discussion: While validation in a larger cohort of patients is necessary, our limited experience have shown satisfactory clinical outcomes without adverse events. Conclusions: Use of incompatible group A or B plasma is a viable option when group AB plasma is limited.

Original languageEnglish
Pages (from-to)628-633
Number of pages6
JournalJournal of Clinical Apheresis
Volume36
Issue number4
DOIs
StatePublished - Aug 2021

Keywords

  • desensitization
  • hemolysis
  • incompatible
  • plasma
  • safety
  • therapeutic plasma exchange

Fingerprint

Dive into the research topics of 'Evaluation of safety of using incompatible plasma for therapeutic plasma exchange during shortage of AB plasma'. Together they form a unique fingerprint.

Cite this